Biologically optimized 3-dimensional in vivo predictive assay-based radiation therapy using positron emission...

Area of Science:

• Oncology
• Medical Imaging
• Radiation Therapy

Background:

• Accurate tumor imaging and predicting radiation sensitivity are crucial for effective cancer treatment.
• Current methods may not fully account for individual tumor responses or treatment delivery uncertainties.

Purpose of the Study:

• To establish Positron Emission Tomography-Computed Tomography (PET-CT) as a tool for in vivo assessment of tumor radiation sensitivity.
• To utilize early-treatment PET-CT imaging for adaptive radiation therapy (ART) and dose-response quantification.

Main Methods:

• Employing dual early-course PET-CT scans to quantify tumor responsiveness and functional cell loss.
• Developing equations to derive tumor responsiveness and guide adaptive treatment adjustments.
• Utilizing high-energy photon/hadron therapy and intrinsic PET emitters for in vivo dose delivery imaging.

Main Results:

• PET-CT allows quantification of tumor responsiveness and cell loss within the first 1.5 weeks of therapy.
• This enables accurate dose-response relation assessment and correction of treatment plan deviations.
• In vivo imaging of integral dose delivery is possible with advanced radiation modalities.

Conclusions:

• PET-CT imaging provides critical data for biologically optimized adaptive radiation therapy (BIO-ART).
• This approach allows for precise correction of geometric, planning, and equipment-related uncertainties.
• BIO-ART optimizes radiation therapy by accounting for individual patient response, hypoxia, and resistance, moving towards an exact science.